Cardiovascular Disorders and COVID-19: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{mitra}} | ||
==Overview== | ==Overview== | ||
| Line 7: | Line 7: | ||
==Complications== | ==Complications== | ||
=== | ===Acute Coronary Syndromes=== | ||
* | * | ||
=== | ===Heart Failure=== | ||
=== | ===Cardiogenic Shock=== | ||
=== | ===Myocarditis=== | ||
===Pericarditis=== | |||
===Arrythmias=== | |||
==References== | ==References== | ||
Revision as of 20:49, 11 June 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mitra Chitsazan, M.D.[2]